Back to Search Start Over

Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

Authors :
Hoppe RT
Advani RH
Ai WZ
Ambinder RF
Armand P
Bello CM
Benitez CM
Bierman PJ
Boughan KM
Dabaja B
Gordon LI
Hernandez-Ilizaliturri FJ
Herrera AF
Hochberg EP
Huang J
Johnston PB
Kaminski MS
Kenkre VP
Khan N
Lynch RC
Maddocks K
McConathy J
McKinney M
Metzger M
Morgan D
Mulroney C
Rabinovitch R
Rosenspire KC
Seropian S
Tao R
Winter JN
Yahalom J
Burns JL
Ogba N
Source :
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2020 Jun; Vol. 18 (6), pp. 755-781.
Publication Year :
2020

Abstract

The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN panel meets at least annually to review comments from reviewers within their institutions, examine relevant data, and reevaluate and update their recommendations. Current management of classic HL involves initial treatment with chemotherapy alone or combined modality therapy followed by restaging with PET/CT to assess treatment response. Overall, the introduction of less toxic and more effective regimens has significantly advanced HL cure rates. This portion of the NCCN Guidelines focuses on the management of classic HL.

Details

Language :
English
ISSN :
1540-1413
Volume :
18
Issue :
6
Database :
MEDLINE
Journal :
Journal of the National Comprehensive Cancer Network : JNCCN
Publication Type :
Academic Journal
Accession number :
32502987
Full Text :
https://doi.org/10.6004/jnccn.2020.0026